Pharma firm in storm over 'sub-standard medicines'

A generic pharmaceutical manufacturer has been accused of selling substandard medicines in order to win approval from European drug regulators.

Susan Mitchell

Deputy Editor and Health Editor @susmitchellsbp
25th May, 2013

A generic pharmaceutical manufacturer, which has a plant in Ireland and sells into the significant Irish market, has been accused of selling substandard medicines and submitting false data in order to win approval from European drug regulators.

The damaging claims were published in a lengthy feature about Ranbaxy, which has a plant in County Tipperary, in Fortune magazine last weekend.

Fortune published, for the first time, multiple accounts from current and former company insiders, backed...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Get basic

*New subscribers only

You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

The year in review

Legacy Richie Oakley 11 months ago

Newsround: What Thursday’s papers say

Legacy Leanna Byrne 5 years ago

More cycle routes, expansion of Luas to Bray and new bus network proposed

Legacy Digital Desk 5 years ago